Cargando…
The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma
BACKGROUND: The role of fulvestrant in the management of intestinal obstruction associated with lobular carcinoma has not been specifically described. CASE PRESENTATION: Herein we present two cases where fulvestrant, as the only available parenteral endocrine agent for postmenopausal advanced breast...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613396/ https://www.ncbi.nlm.nih.gov/pubmed/19046426 http://dx.doi.org/10.1186/1477-7819-6-128 |
_version_ | 1782163175758626816 |
---|---|
author | Tang, Jasmine YM Rampaul, Rajendra Singh Cheung, Kwok L |
author_facet | Tang, Jasmine YM Rampaul, Rajendra Singh Cheung, Kwok L |
author_sort | Tang, Jasmine YM |
collection | PubMed |
description | BACKGROUND: The role of fulvestrant in the management of intestinal obstruction associated with lobular carcinoma has not been specifically described. CASE PRESENTATION: Herein we present two cases where fulvestrant, as the only available parenteral endocrine agent for postmenopausal advanced breast cancer has the opportunity to provide a means to initiate treatment in those patients who present with varying degrees of intestinal obstruction. CONCLUSION: Fulvestrant may obviate the use of chemotherapy while achieving sustained clinical benefit with less toxicity, in appropriately selected patients. |
format | Text |
id | pubmed-2613396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26133962009-01-03 The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma Tang, Jasmine YM Rampaul, Rajendra Singh Cheung, Kwok L World J Surg Oncol Case Report BACKGROUND: The role of fulvestrant in the management of intestinal obstruction associated with lobular carcinoma has not been specifically described. CASE PRESENTATION: Herein we present two cases where fulvestrant, as the only available parenteral endocrine agent for postmenopausal advanced breast cancer has the opportunity to provide a means to initiate treatment in those patients who present with varying degrees of intestinal obstruction. CONCLUSION: Fulvestrant may obviate the use of chemotherapy while achieving sustained clinical benefit with less toxicity, in appropriately selected patients. BioMed Central 2008-12-01 /pmc/articles/PMC2613396/ /pubmed/19046426 http://dx.doi.org/10.1186/1477-7819-6-128 Text en Copyright © 2008 Tang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Tang, Jasmine YM Rampaul, Rajendra Singh Cheung, Kwok L The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma |
title | The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma |
title_full | The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma |
title_fullStr | The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma |
title_full_unstemmed | The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma |
title_short | The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma |
title_sort | use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613396/ https://www.ncbi.nlm.nih.gov/pubmed/19046426 http://dx.doi.org/10.1186/1477-7819-6-128 |
work_keys_str_mv | AT tangjasmineym theuseoffulvestrantaparenteralendocrineagentinintestinalobstructionduetometastaticlobularbreastcarcinoma AT rampaulrajendrasingh theuseoffulvestrantaparenteralendocrineagentinintestinalobstructionduetometastaticlobularbreastcarcinoma AT cheungkwokl theuseoffulvestrantaparenteralendocrineagentinintestinalobstructionduetometastaticlobularbreastcarcinoma AT tangjasmineym useoffulvestrantaparenteralendocrineagentinintestinalobstructionduetometastaticlobularbreastcarcinoma AT rampaulrajendrasingh useoffulvestrantaparenteralendocrineagentinintestinalobstructionduetometastaticlobularbreastcarcinoma AT cheungkwokl useoffulvestrantaparenteralendocrineagentinintestinalobstructionduetometastaticlobularbreastcarcinoma |